GnRH agonists and antagonists decrease the metastatic progression of human prostate cancer cell lines by inhibiting the plasminogen activator system.

Abstract:

:Prostate cancer (PCa) growth initially depends on circulating androgens. Gonadotropin-releasing hormone (GnRH) agonists are currently used for the treatment of PCa. However, after an initial responsiveness to hormonal deprivation, PCa progresses and metastasizes. Recently, also GnRH antagonists have been used for clinical trials in patients with PCa and the results seem promising. The components of the plasminogen activator (PA) system (urokinase-type PA, uPA; PA inhibitors, PAI-1/2; uPA receptor, uPAR) have been implicated in the local degradation of the extracellular matrix (ECM) and PCa progression. The aim of this study was to test the possible effects of the treatment with an agonist (Leuprolide, GnRH-A) and an antagonist (Cetrorelix, GnRH-ANT) of GnRH on the expression and activity of uPA and PAI-1 in the conditioned media of DU145 and PC3, two PCa androgen-independent cell lines. The involvement of the PA system in the control of cellular migration was also investigated. The results obtained in DU145 and PC3 cells show that both GnRH-A and GnRH-ANT: i) inhibit cell proliferation; ii) significantly decrease the enzymatic activity and the secretion of uPA; iii) significantly increase the protein levels of PAI-1; iv) induce a significant decrease of the migratory and invasion PCa capabilities. This study suggests that GnRH analogues exhibit not only an antiproliferative effect, but also an anti-metastatic action exerted through the inhibition of the activity of PA system and might provide a rational basis for the development of clinical strategies for those tumours that progress towards an androgen-independent condition characterized by a higher metastatic potential.

journal_name

Oncol Rep

journal_title

Oncology reports

authors

Dondi D,Festuccia C,Piccolella M,Bologna M,Motta M

doi

10.3892/or.15.2.393

keywords:

subject

Has Abstract

pub_date

2006-02-01 00:00:00

pages

393-400

issue

2

eissn

1021-335X

issn

1791-2431

journal_volume

15

pub_type

杂志文章
  • Low expression of PinX1 is associated with malignant behavior in basal-like breast cancer.

    abstract::Human Pinx1 protein, associated with shelterin proteins, is widely revealed as a haploinsufficient tumor suppressor. Growing evidence has manifested the deregulation of PinX1 in distinct cancers. Nonetheless, the loss status of PinX1 and its diagnostic, prognostic and clinicopathological significance in Basal-like bre...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2017.5696

    authors: Feng YZ,Zhang QY,Fu MT,Zhang ZF,Wei M,Zhou JY,Shi R

    更新日期:2017-07-01 00:00:00

  • 5-Fluorouracil combined with apigenin enhances anticancer activity through induction of apoptosis in human breast cancer MDA-MB-453 cells.

    abstract::We investigated the effects of combined treatment with 5-fluorouracil and apigenin on proliferation and apoptosis, as well as the underlying mechanism, in human breast cancer MDA-MB-453 cells. The MDA-MB-453 cells, which have been shown to overexpress ErbB2, were resistant to 5-fluorouracil; 5-fluorouracil exhibited a...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or_00000598

    authors: Choi EJ,Kim GH

    更新日期:2009-12-01 00:00:00

  • Cancer-associated fibroblasts do not respond to combined irradiation and kinase inhibitor treatment.

    abstract::The emergence of radioresistance is a significant issue in the treatment of squamous cell carcinoma. We recently demonstrated that post-radiogenic extracellular signal-regulated kinase (ERK) signaling might decrease radiosensitivity in this cancer type. To further elucidate how tumo...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2012.2180

    authors: Affolter A,Schmidtmann I,Mann WJ,Brieger J

    更新日期:2013-02-01 00:00:00

  • Establishment of a human primary pancreatic cancer mouse model to examine and investigate gemcitabine resistance.

    abstract::Pancreatic cancer is one of the most fatal types of cancer and is associated with a dismal prognosis. Gemcitabine-based chemotherapy is clinically used for the treatment of advanced pancreatic cancer. However, many forms of pancreatic cancer have acquired resistance to gemcitabine. In order to prevent patients from su...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2017.6026

    authors: Zhang YJ,Wen CL,Qin YX,Tang XM,Shi MM,Shen BY,Fang Y

    更新日期:2017-12-01 00:00:00

  • Ginsenoside Rg3 induces apoptosis in the U87MG human glioblastoma cell line through the MEK signaling pathway and reactive oxygen species.

    abstract::Ginsenoside is known to have potential cancer-preventive activities. The major active components in red ginseng consist of a variety of ginsenosides including Rg3, Rg5 and Rk1, each of which has different pharmacological activities. Among these, Rg3 has been reported to exert anticancer activities through inhibition o...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2013.2555

    authors: Choi YJ,Lee HJ,Kang DW,Han IH,Choi BK,Cho WH

    更新日期:2013-09-01 00:00:00

  • Unique antineoplastic profile of Saquinavir-NO, a novel NO-derivative of the protease inhibitor Saquinavir, on the in vitro and in vivo tumor formation of A375 human melanoma cells.

    abstract::We have recently shown that covalent attachment of the nitric oxide (NO) moiety to the HIV protease inhibitor Saquinavir (Saq) produced a qualitatively new chemical entity, named Saquinavir-NO (Saq-NO), with enhanced anticancer properties and reduced toxicity both in vitro and in vi...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2012.1840

    authors: Donia M,Mangano K,Fagone P,De Pasquale R,Dinotta F,Coco M,Padron J,Al-Abed Y,Giovanni Lombardo GA,Maksimovic-Ivanic D,Mijatovic S,Zocca MB,Perciavalle V,Stosic-Grujicic S,Nicoletti F

    更新日期:2012-08-01 00:00:00

  • Cytokinetic analysis of cell cycle and sub-phases in MOLT-4 cells by cyclin E + A/DNA multiparameter flow cytometry.

    abstract::Cell cycle analysis has become increasingly important in verifying the effect of anti-tumor drugs and cytokinetic research. In the early methods of cell cycle analysis, the flow cytometry relied on DNA content, and therefore, the cell cycle could be only broken into three stages: G(0)/G(1), S, and G(2)/M phase. It cou...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:

    authors: Qin J,Tao D,Duan R,Leng Y,Shen M,Zhou H,Feng Y,Gao C,Yu Y,Li QQ,Hu J,Gong J

    更新日期:2002-09-01 00:00:00

  • Transcriptional silencing of ETS-1 abrogates epithelial-mesenchymal transition resulting in reduced motility of pancreatic cancer cells.

    abstract::v-ets erythroblastosis virus E26 oncogene homolog 1 (ETS-1) plays crucial roles in a spectrum of malignancies. ETS-1 has gained attention in cancer research for its importance in cell migration, invasion and proliferation. In the present study, we focused on the effect of ETS-1 on epithelial-mesenchymal transition (EM...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2014.3613

    authors: Li C,Wang Z,Chen Y,Zhou M,Zhang H,Chen R,Shi F,Wang C,Rui Z

    更新日期:2015-02-01 00:00:00

  • Possible involvement of TGF‑β‑SMAD‑mediated epithelial‑mesenchymal transition in pro‑metastatic property of PAX6.

    abstract::Paired box 6 (PAX6) is a transcription factor that has oncogenic features. In breast cancer, PAX6 facilitates tumor progression; however, the underlying mechanism is largely unknown. The majority of breast cancer‑related mortalities are associated with metastasis of cancer cells. Therefore, the present study aimed to ...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2020.7644

    authors: Jin M,Gao D,Wang R,Sik A,Liu K

    更新日期:2020-08-01 00:00:00

  • A polymorphism C3435T of the MDR-1 gene associated with smoking or high body mass index increases the risk of sporadic breast cancer in women.

    abstract::The human multidrug resistance gene 1 (MDR-1) encodes a plasma membrane P-glycoprotein (P-gp) that functions as the transmembrane efflux pump for various structurally unrelated anticancer agents and toxins. Polymorphisms in the MDR-1 gene may have an impact on the expression and function of P-gp, thereby influencing t...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:

    authors: Zubor P,Lasabova Z,Hatok J,Stanclova A,Danko J

    更新日期:2007-07-01 00:00:00

  • Role of ERCC5 polymorphisms in non‑small cell lung cancer risk and responsiveness/toxicity to cisplatin‑based chemotherapy in the Chinese population.

    abstract::Non‑small cell lung cancer (NSCLC) is the leading cause of cancer‑related deaths worldwide. Cisplatin‑based chemotherapy currently represents the main treatment option for patients with NSCLC. The aim of the present study was to evaluate effect of single nucleotide polymorphisms (SNPs) within the excision repair cross...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2021.7935

    authors: Li M,Chen R,Ji B,Fan C,Wang G,Yue C,Jin G

    更新日期:2021-01-14 00:00:00

  • 5-aza-2'-deoxycytidine sensitizes hepatoma and pancreatic cancer cell lines.

    abstract::Hepatocellular carcinoma (HCC) and pancreatic cancer are at the forefront of chemotherapy-resistant tumors with poor prognosis. Even with innovative treatment regimens, response rates remain low and the duration of response is short. We examined whether the suppression of DNA methylation was capable of enhancing the s...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:

    authors: Kanda T,Tada M,Imazeki F,Yokosuka O,Nagao K,Saisho H

    更新日期:2005-10-01 00:00:00

  • Effects of zinc finger protein 403 on the proliferation, migration and invasion abilities of prostate cancer cells.

    abstract::Zinc finger protein 403 (ZFP403), located on human chromosome 17q12‑21, is closely associated with the development of cancer. However, to date, there are a limited number of studies on the biological functions of this gene, particularly in prostate cancer (PCa). The results of the present study demonstrated that compa...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2020.7786

    authors: Xu X,Zhu Z,Xu Y,Tian S,Jiang Y,Zhao H

    更新日期:2020-12-01 00:00:00

  • Neuregulin-1 induces cancer stem cell characteristics in breast cancer cell lines.

    abstract::In breast cancer, neuregulin-1 (NRG1) is known as a ligand for the HER3 receptor, which has no intrinsic tyrosine kinase activity. When activated by NRG1 binding, the HER3 receptor forms a heterodimer with other HER family receptors and mediates downstream signaling pathways, leading to multiple effects including grow...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2014.3330

    authors: Jeong H,Kim J,Lee Y,Seo JH,Hong SR,Kim A

    更新日期:2014-09-01 00:00:00

  • HSPA9 overexpression inhibits apoptin-induced apoptosis in the HepG2 cell line.

    abstract::Apoptin, a small protein derived from chicken anemia virus, possesses the capacity to specifically kill tumor cells while leaving normal cells intact. Previous studies have indicated that the subcellular localization of apoptin appears to be crucial for this tumor-selective activity. Apoptin resides in the cytoplasm o...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2013.2399

    authors: Peng C,Yang P,Cui Y,He M,Liang L,Di Y

    更新日期:2013-06-01 00:00:00

  • Expression of circular RNA CDR1‑AS in colon cancer cells increases cell surface PD‑L1 protein levels.

    abstract::The expression of CDR1‑AS, a representative circular RNA, is closely linked with poor prognosis in gastrointestinal cancers, such as colon, liver, and pancreatic cancers. Although it is well known that CDR1‑AS antagonizes microRNA‑7 function through its sequence similarities in the brain, its biological function and l...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2019.7244

    authors: Tanaka E,Miyakawa Y,Kishikawa T,Seimiya T,Iwata T,Funato K,Odawara N,Sekiba K,Yamagami M,Suzuki T,Ishibashi R,Otsuka M,Koike K

    更新日期:2019-10-01 00:00:00

  • Resolvin D1 and E1 alleviate the progress of hepatitis toward liver cancer in long-term concanavalin A-induced mice through inhibition of NF-κB activity.

    abstract::Resolvins, an endogenous lipid mediator derived from eicosapentaenoic acid (EPA) or docosahexaenoic acid (DHA) of fish oil, has been reported to have anti-inflammatory and antitumor effect in various pathogenic processes. However, there are no studies about the effects of resolvin D1 and E1 on concanavalin A-induced h...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2015.4389

    authors: Kuang H,Hua X,Zhou J,Yang R

    更新日期:2016-01-01 00:00:00

  • DEK protein overexpression predicts poor prognosis in pancreatic ductal adenocarcinoma.

    abstract::DEK, a transcription factor, is involved in mRNA splicing, transcriptional control, cell division and differentiation. Recent studies suggest that DEK overexpression can promote tumorigenesis in a wide range of cancer cell types. However, little is known concerning the status of DEK in pancreatic ductal adenocarcinoma...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2016.5302

    authors: Sun J,Bi F,Yang Y,Zhang Y,Jin A,Li J,Lin Z

    更新日期:2017-02-01 00:00:00

  • Interference of STAT 5b expression enhances the chemo-sensitivity of gastric cancer cells to gefitinib by promoting mitochondrial pathway-mediated cell apoptosis.

    abstract::Signal transducer and activator of transcription (STAT) 5, including STAT 5a and STAT 5b, was reported to play important roles in the malignant biological behaviors of tumors. However, their roles in gastric cancer, especially for STAT 5b remain unknown. This study aimed to detect the expression of STAT 5b in gastric ...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2015.3994

    authors: Sun T,Jia Y,Xiao D

    更新日期:2015-07-01 00:00:00

  • A new version of targeted minicircle producer system for EBV-positive human nasopharyngeal carcinoma.

    abstract::Targeted gene therapy needs to be implemented for future therapies to ensure efficient activity at the site of patient primary tumors or metastases without causing intolerable side-effects. One of the elements of gene therapy is vector, which includes viral and non-viral vector. In the present study, we constructed a ...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2014.3486

    authors: Zuo Y,Liao S,Xu Z,Xie J,Huang W,Yu Z

    更新日期:2014-12-01 00:00:00

  • Ribozyme mediated down-regulation of thrombospondin receptor CD36 inhibits the growth of the human osteosarcoma cell line.

    abstract::Thrombospondin-1 (TSP1) is known to possess tumor suppressor functions. In contradiction, TSP1 enhances the stromal vascularization and growth of certain cancers. A cell adhesion receptor, CD36, has been shown to interact with a ligand TSP1. We studied how CD36 affects the growth of the osteosarcoma cell line (HOS) ex...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:

    authors: Yamazaki H,Handa A,Nishi M,Tokunaga T,Tomisawa M,Hatanaka H,Abe Y,Kijima H,Ueyama Y,Nakamura M

    更新日期:2004-02-01 00:00:00

  • Effects of 2-methoxyestradiol on apoptosis and HIF-1α and HIF-2α expression in lung cancer cells under normoxia and hypoxia.

    abstract::Hypoxic tumor cells are known to be more resistant to conventional chemotherapy and radiation than normoxic cells. However, the effects of 2-methoxyestradiol (2-ME), an anti-angiogenic, antiproliferative and pro-apoptotic drug, on hypoxic lung cancer cells are unknown. The aim of the present study was to compare the e...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2015.4399

    authors: Aquino-Gálvez A,González-Ávila G,Delgado-Tello J,Castillejos-López M,Mendoza-Milla C,Zúñiga J,Checa M,Maldonado-Martínez HA,Trinidad-López A,Cisneros J,Torres-Espíndola LM,Hernández-Jiménez C,Sommer B,Cabello-Gutiérrez C,Guti

    更新日期:2016-01-01 00:00:00

  • microRNA-330 inhibits cell motility by downregulating Sp1 in prostate cancer cells.

    abstract::microRNAs (miRNAs), small non-coding RNAs, have emerged as key regulators of a large number of genes. The present study aimed to explore novel biological functions of miR-330 in the human prostate cancer cell lines DU145 and PC3. We confirmed that miR-330 was downregulated and inversely correlated with specificity pro...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2013.2452

    authors: Mao Y,Chen H,Lin Y,Xu X,Hu Z,Zhu Y,Wu J,Xu X,Zheng X,Xie L

    更新日期:2013-07-01 00:00:00

  • Evaluation of the novel gene Rabl3 in the regulation of proliferation and motility in human cancer cells.

    abstract::Rab is a large subfamily of small GTPases which play an important role in multiple processes relating to cellular transportation and modulation of the cytoskeleton. Novel gene Rab-like 3 (Rabl3), which we originally reported as a new member belonging to this subfamily, may participate in other processes in human cance...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or_00000876

    authors: Li Q,Wang L,Zeng L,Zhang Y,Li K,Jin P,Su B,Wang L

    更新日期:2010-08-01 00:00:00

  • Dysregulation of signaling pathways and putative biomarkers in liver cancer stem cells (Review).

    abstract::Hepatocellular carcinoma (HCC) is one of the most common tumors in the world. At present, the details of the mechanism responsible for HCC formation and maintenance remain unclear. However, the cancer stem cell (CSC) theory suggests that liver cancer stem cells (LCSCs) may be respon...

    journal_title:Oncology reports

    pub_type: 杂志文章,评审

    doi:10.3892/or.2012.2082

    authors: Song K,Wu J,Jiang C

    更新日期:2013-01-01 00:00:00

  • Long non-coding RNA SNHG1 predicts a poor prognosis and promotes colon cancer tumorigenesis.

    abstract::Colon cancer is the main cause of cancer mortality worldwide. Its poor prognosis is mainly ascribed to high recurrence rates. Identifying novel prognostic biomarkers and therapeutic key points for management is crucial and important. Long non-coding RNAs (lncRNAs) are a class of RNAs, which have various roles in carci...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2018.6412

    authors: Yang H,Wang S,Kang YJ,Wang C,Xu Y,Zhang Y,Jiang Z

    更新日期:2018-07-01 00:00:00

  • Matrine inhibits the metastatic properties of human cervical cancer cells via downregulating the p38 signaling pathway.

    abstract::Matrine is a traditional Chinese herbal medicine that shows antitumor efficacy for many types of cancer. The present study evaluated the antitumor efficacy of matrine on cervical cancer and to investigate the underlying mechanisms. We performed MTT assays, and in vitro invasion and migration assays, and P1 L6 found th...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2017.5787

    authors: Wu X,Zhou J,Cai D,Li M

    更新日期:2017-08-01 00:00:00

  • Investigating the relationship between serum thrombopoietin kinetics and the platelet-sparing effect: A clinical pharmacological evaluation of combined paclitaxel and carboplatin in patients with non-small cell lung cancer.

    abstract::We conducted a clinical pharmacological evaluation of paclitaxel/carboplatin combination in Japanese patients with non-small cell lung cancer. The purpose of this study was to identify the optimal dose of this combination and to investigate the relationships between the pharmacokinetic profiles of these 2 drugs, serum...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:

    authors: Daga H,Isobe T,Miyazaki M,Fujitaka K,Kondo K,Kohno N

    更新日期:2004-06-01 00:00:00

  • Aberrant expression of class III beta-tubulin in basal cell carcinoma of the skin.

    abstract::Tubulin is a major component of microtubules. Class III beta-tubulin (beta III) is a neuron-associated beta-tubulin isotype and expressed in the normal central and peripheral nervous systems. According to a previous study, beta III is not expressed in normal skin and squamous cell carcinoma. However, its expression ha...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or_00000494

    authors: Ishida M,Kushima R,Okabe H

    更新日期:2009-10-01 00:00:00

  • Antitumor effect of gefitinib on head and neck squamous cell carcinoma enhanced by trastuzumab.

    abstract::The overexpression of EGFR and/or HER-2 is associated with tumor cell resistance to chemotherapy, radiotherapy, disease progression and poor prognosis in patients with a variety of malignant tumors. Treatment combining the EGFR-targeting drug, gefitinib (ZD1839, Iressa) with the HER-2-targeting drug, trastuzumab (Herc...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:

    authors: Kondo N,Ishiguro Y,Kimura M,Sano D,Fujita K,Sakakibara A,Taguchi T,Toth G,Matsuda H,Tsukuda M

    更新日期:2008-08-01 00:00:00